2007
DOI: 10.1016/j.ijpharm.2006.08.003
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of an eucalyptus oil containing topical drug delivery system for selected steroid hormones

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
27
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 64 publications
(27 citation statements)
references
References 35 publications
0
27
0
Order By: Relevance
“…27,28) eucalyptus oil/ cineole has been shown to enhance the skin penetration of many drugs under in vitro conditions. [29][30][31][32] To our knowledge, this is the first time eucalyptus oil/cineole has been used in a human clinical trial. During our pharmacokinetic studies, no adverse events were reported and no signs of skin irritation/ sensitization were observed.…”
Section: Discussionmentioning
confidence: 90%
“…27,28) eucalyptus oil/ cineole has been shown to enhance the skin penetration of many drugs under in vitro conditions. [29][30][31][32] To our knowledge, this is the first time eucalyptus oil/cineole has been used in a human clinical trial. During our pharmacokinetic studies, no adverse events were reported and no signs of skin irritation/ sensitization were observed.…”
Section: Discussionmentioning
confidence: 90%
“…Polydispersity index (PDI) is an important parameter in the characterization of colloidal drug carriers since it reflects the physical stability of the system and provides information about homogeneity of the samples 29,30 . The PDI values lower than 0.4 indicated homogenous microemulsion systems with narrow size distribution in our study.…”
Section: Droplet Size Measurementsmentioning
confidence: 99%
“…Several hypotheses have been put forward for the mechanism of drug permeation enhancement. These include increased drug solubility, which fosters a high concentration gradient towards skin, small droplet size and low viscosity which facilitates permeation, increased drug thermodynamic activity in the microemulsion vehicle, and the disruption of the stratum corneum lipid order by microemulsion components (Kreilgaard, 2002;Zhao et al, 2006;Biruss, Kählig, Valenta, 2007;Gupta, Moulik, 2008;Vicentini et al, 2008;Moniruzzaman, Kamiya, Goto, 2010;Shakeel, Ramadan, 2010).…”
Section: Introductionmentioning
confidence: 99%